Seguimiento clínico del ensayo de una vacuna VLP para los serotipos 1 y 1+4 de la lengua azul en ganado ovino
Abstract
Bluetongue Virus disease is an infectous disease submitted to a sanitary control composed by several measures of prevention, and one of these measures is the vaccination of the sensible species. In the development of vaccines opposite to this disease, a new trend is the production of polyvalent vaccines by VLP's technology (virus like particles). This work has had as aim to value by clinical survey, 2 VLP vaccines, for serotypes 1 and 1+4. The results confirm the lack of fever, clinical signs and pathologic injuries in vaccinated animals opposite to control animals, which indicates that these new vaccines protect for the appearance of clinical signs.Downloads
Article download
Crossmark
License
In order to support the global exchange of knowledge, the journal Revista Complutense de Ciencias Veterinarias is allowing unrestricted access to its content as from its publication in this electronic edition, and as such it is an open-access journal. The originals published in this journal are the property of the Complutense University of Madrid and any reproduction thereof in full or in part must cite the source. All content is distributed under a Creative Commons Attribution 4.0 use and distribution licence (CC BY 4.0). This circumstance must be expressly stated in these terms where necessary. You can view the summary and the complete legal text of the licence.
Revista Complutense de Ciencias Veterinarias is an open access journal that does not charge authors for article processing (submission, review or editing) or publication.
